Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Headlines

(FatCamera/iStock via Getty Images Plus)

AML digital therapeutic lands Breakthrough Device Designation from FDA

Blue Note Therapeutics has announced the status has been granted to BNT200, a device to treat anxiety and depression in acute myeloid leukemia patients.

Vanderbilt discovery offers hope for colorectal cancer patients

The researchers, in studying how polyps morph into colorectal cancer, have set a path for improved surveillance of the disease, harnessing precision medicine.

San Diego cell therapy CDMO acquired by Great Point Partners

Performance Cell Manufacturing, a CDMO with a focus on manufacturing cell therapies, has been acquired by Great Point Partners and will now operate under the name Cellipont Bioservices.

WHO grants seal of approval to two new COVID-19 treatments

The World Health Organization has recommended the drugs for COVID-19 patients, broadening the range of therapies to combat the virus behind the pandemic.

Pharma R&D investment report shows positive signs: Deloitte

According to the company’s 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.